Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2NET 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Gemcitabine 11pembrolizumab 10Oxaliplatin 7Nivolumab 7Irinotecan 7Fluorouracil 7Capecitabine 7durvalumab 6Sorafenib 6Leucovorin 6Cyclophosphamide 6Paclitaxel 5Ipilimumab 5tislelizumab 3poly ICLC 3lenvatinib 3fludarabine 3Sunitinib 3Radiotherapy 3Cisplatin 3Cetuximab 3130-nm albumin-bound paclitaxel 3seocalcitol 2selinexor 2pemigatinib 2futuximab 2fludarabine phosphate 2donafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × epothilone B × Gastrointestinal × Clear all
NCT00035087 2013-12-04

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Novartis

Phase 2 Completed
62 enrolled
Gastrointestinal

Carcinoma, Colonic Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡